Dendritic Cell (DC) is a newly emerging and potent form of cancer immune therapy. However, the efficacy of antigen-loaded DCs (DC-vaccines) is strongly influenced by their ability to migrate to peripheral draining lymph nodes (LNs). Therefore, it is critical to monitor the in vivo biodistribution of DC-vaccines after vaccination in order to optimize DC therapy for pancreatic cancer. In this study, we propose magnetically labeling DC- vaccines to permit magnetic resonance imaging (MRI) of their migration to LNs. We will use clinically applicable approaches combining FDA-approved drugs (ferumoxytol, heparin, and protamine) for magnetic DC-vaccine labeling, in which magnetic DC-vaccines can be visualized with advanced MRI methods. These techniques may offer future insights into the dynamics and kinetics of DC migration in vivo and the related impacts upon therapeutic outcomes in both pre-clinical and clinical research settings. Additional translational studies should ultimately follow to evaluate the efficacy of these approaches for early prediction of longitudinal outcomes during DC therapy in a broad range of tumor etiologies. This project will address the following Specific Aims using KPC transgenic mouse model of pancreatic cancer.
Aim 1 : To optimize clinically applicable methods for magnetic-labeling of DC-vaccines and determine the quantitative imaging properties of these vaccines with in vitro MRI phantom studies;
Aim 2 : To assess whether magnetic-labeling of the DC-vaccine permits quantitative in vivo MRI of subsequent migration to the draining LNs following DC-based vaccination;
and Aim 3 : To determine whether that MRI monitored DC-vaccine migration to LNs can predict therapy.
Therapeutic outcomes following the dendritic cell (DC)-based vaccination for pancreatic cancer may be limited if an insufficient number of the DC-vaccines reach the draining lymph nodes (LNs). We will use clinically applicable approaches for magnetic DC-vaccine labeling, in which magnetic DC-vaccines can be visualized with advanced MRI methods. Imaging methods will be developed to allow direct, non-invasive, real-time measurements of DC-vaccine homing to draining LNs thus serving as valuable biomarkers for clinical dosimetry as well as the advancement of knowledge and discovery in DC immunotherapy strategies.
|Zhou, Xin; Li, Jing; Guo, Junli et al. (2018) Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome 6:66|
|Xiong, Xuanqi; Zhou, Zhengwei; Figini, Matteo et al. (2018) Multi-parameter evaluation of lumbar intervertebral disc degeneration using quantitative magnetic resonance imaging techniques. Am J Transl Res 10:444-454|
|Su, Zhanliang; Wang, Xifu; Zheng, Linfeng et al. (2018) MRI-guided interventional natural killer cell delivery for liver tumor treatment. Cancer Med 7:1860-1869|
|Wang, Bin; Sun, Chong; Wang, Sijia et al. (2018) Mouse dendritic cell migration in abdominal lymph nodes by intraperitoneal administration. Am J Transl Res 10:2859-2867|
|Cai, Wei; Dong, Yan; Tian, Lu et al. (2018) Predictive Value of Four-Dimensional Strain Echocardiography for Adverse Cardiovascular Outcomes in ST-Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. Cardiology 139:255-264|
|Ji, Yang; Zhang, Chuanshan; Huang, Zhe et al. (2018) Gd-EOB-DTPA DCE-MRI biomarkers in a rabbit model of liver fibrosis. Am J Transl Res 10:2949-2957|
|Sun, Chong; Wang, Bin; Li, Jianmin et al. (2018) Quantitative measurement of breast carcinoma fibrosis for the prediction in the risk of bone metastasis. Am J Transl Res 10:1852-1859|
|Wang, Xifu; Su, Zhanliang; Lyu, Tianchu et al. (2018) 18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model. Radiology 287:137-145|
|Shang, Na; Figini, Matteo; Shangguan, Junjie et al. (2017) Dendritic cells based immunotherapy. Am J Cancer Res 7:2091-2102|
|Lyu, Tianchu; Wang, Xifu; Su, Zhanliang et al. (2017) Irreversible electroporation in primary and metastatic hepatic malignancies: A review. Medicine (Baltimore) 96:e6386|
Showing the most recent 10 out of 21 publications